Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.semnephrol.2008.05.010 http://scihub22266oqcxt.onion/10.1016/j.semnephrol.2008.05.010 18790370!2597020!18790370     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Semin+Nephrol 2008 ; 28 (5): 493-8 Nephropedia Template TP {{tp|p=18790370|t=2008. The future of pediatric acute kidney injury management--biomarkers |pdf=|usr=}}{{18790370}} gab.com Text The future of pediatric acute kidney injury management--biomarkers JO: Semin Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=18790370 #FOAvip Acute kidney injury (AKI) represents a common and devastating problem in clinical medicine. A major reason is the lack of early biomarkers for AKI, and hence an unacceptable delay in initiating therapy. Fortunately, the application of innovative technologies has uncovered several novel biomarkers. The most promising of these are included in a putative AKI biomarker panel, consisting of neutrophil gelatinase-associated lipocalin, interleukin-18, and kidney injury molecule-1. These biomarkers have completed initial validation, and have entered the prospective screening stage in the biomarker development process, facilitated by the development of commercial tools for their reproducible measurement across laboratories. The availability of a panel of validated biomarkers will revolutionize renal and critical care, and enable the practice of personalized and predictive medicine at an unprecedented level. Twit Text FOAVip The future of pediatric acute kidney injury management--biomarkers ????Semin Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=18790370 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=18790370 #FOAvip English Wikipedia <ref>{{Cite pmid|18790370}}</ref> The future of pediatric acute kidney injury management--biomarkers #MMPMID18790370 Devarajan P Semin Nephrol 2008[Sep]; 28 (5): 493-8 PMID18790370show ga Acute kidney injury (AKI) represents a common and devastating problem in clinical medicine. A major reason is the lack of early biomarkers for AKI, and hence an unacceptable delay in initiating therapy. Fortunately, the application of innovative technologies has uncovered several novel biomarkers. The most promising of these are included in a putative AKI biomarker panel, consisting of neutrophil gelatinase-associated lipocalin, interleukin-18, and kidney injury molecule-1. These biomarkers have completed initial validation, and have entered the prospective screening stage in the biomarker development process, facilitated by the development of commercial tools for their reproducible measurement across laboratories. The availability of a panel of validated biomarkers will revolutionize renal and critical care, and enable the practice of personalized and predictive medicine at an unprecedented level. |Acute Kidney Injury/*metabolism[MESH] |Biomarkers/*analysis[MESH] |Child[MESH] |Humans[MESH] |Prognosis[MESH]The future of pediatric acute kidney injury management--biomarkers (epmc).pdf DeepDyve Pubget Overpricing